Navigation Links
Susan G. Komen for the Cure Names Tim Doke Chief Marketing Officer
Date:12/12/2007

Thirty-year Communications Veteran Tasked with Expanding Opportunities for

People to Engage with the World's Largest Breast Cancer Organization

DALLAS, Dec. 12 /PRNewswire/ -- Tim Doke, one of the most recognized marketing and communications professionals, today was named chief marketing officer for Susan G. Komen for the Cure, the world's largest grassroots network of breast cancer survivors and activists.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO)

Doke joins Komen for the Cure after serving as a communications executive for some of the world's largest companies and agencies including American Airlines, Brinker International, Dell, Freescale Semiconductor and Hill & Knowlton. As a result of his work at American Airlines during and following the events of 9/11, he was recognized in 2002 as the Public Relations Professional of the Year by the Public Relations Society of America.

"Tim has a proven track record in building brands and a deep understanding of what makes consumers tick," said Hala Moddelmog, Susan G. Komen for the Cure president and CEO. "His experience comes at a critical time as Komen raises the momentum of the global breast cancer movement to the next level, and works to achieve our goal of investing another $2 billion in breast cancer research and community outreach programs in the next 10 years in order to discover and deliver the cures."

Helping Komen to Engage New Activists

In his new role, Doke will work to expand opportunities for people to engage with Komen and to empower them with quality resources. He will oversee the areas of cause marketing, sponsorships, multicultural marketing, public policy, brand marketing, merchandising, communications and events.

"Susan G. Komen for the Cure has built an amazing brand with a powerful identity as the pioneer of the global breast cancer movement and voice for those who have had no one to represent them," said Doke. "Now, as the organization marks its 25th anniversary and the breast cancer movement is reaching critical momentum, is an unprecedented opportunity to build upon Komen's reputation and engage new activists in our effort to save lives and end breast cancer forever."

Doke's Background

Doke has extensive national and international experience in strategic communications, public affairs, advertising and branding, marketing, media relations, crisis communications, internal communications, litigation PR, issues management and corporate giving and foundation management. Doke has worked closely with CEOs on all areas of reputation management and brand protection.

About Susan G. Komen for the Cure

Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure, we have invested nearly $1 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. For more information about Susan G. Komen for the Cure, breast health or breast cancer, visit http://www.komen.org or call 1-877 GO KOMEN.


'/>"/>
SOURCE Susan G. Komen for the Cure
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PRA International Adds Dr. Susan Stansfield as Executive Vice President
2. In Celebration of Breast Cancer Awareness Month, Susan G. Komen for the Cure San Diego Announces Opportunities for San Diegans to Get Involved in the Fight Against Breast Cancer
3. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
4. Arthur M. Blank Family Foundation Names Susan Bertonaschi Program Officer, Better Beginnings
5. Forbes Honors Susan G. Komen for the Cure Founder as Trailblazer
6. Celebrities Pledge to Wear Pink, End Breast Cancer Forever With Susan G. Komen for the Cure
7. PNY Technologies and Susan G. Komen for the Cure Partner to Raise Awareness of Breast Cancer
8. Susan G. Komen for the Cure Partners With the Original Butter Bell(R) Crock Developer
9. Susan G. Komen for the Cures Phoenix Affiliate, State Officials, Survivors and Advocates Call for Action on Breast Cancer
10. Susan G. Komen for the Cure Launches Unprecedented Global Expansion Program in 10 Countries
11. Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... ... medical device compliance and commercialization, has just released a new white paper ... is more adamant than ever about medical device, pharmaceutical, and combination product ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... and industry-leading compliance software, The Guard®, has helped another long-time client pass their ... audit and properly satisfy the law. , Thanks to the help of the ...
(Date:9/20/2017)... ... , ... The Centers for Medicare and Medicaid Services (CMS) stated in the ... only Worksheet S-10 to distribute Disproportionate Share Hospital (DSH) Uncompensated Care Payments over the ... on October 17, 2017 at 2 P.M. EST and uncover how you can ...
(Date:9/20/2017)... ... 2017 , ... “RECYCLED Ezekiel's Plan for Freedom from ADDICTION”: ... ADDICTION” is the creation of published author, Bill Miller. Bill Miller has ... including more than a decade of addiction to prescription drugs. He has ...
(Date:9/20/2017)... ... , ... “The Foggy Road to Moorwick”: the adventures of a young Scottish girl yearning to ... Jeanine Liston, a busy mother of five who used her time waiting for children to ... for over twenty years. It was a way to give some meaning to the ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the ... has been granted Fast Track status by the US Food ... HCl) followed by NRX-101 (D-cycloserine + lurasidone). The company will ... sequential therapy targeting patients who are admitted to Emergency Departments ... ...
(Date:9/5/2017)... 2017  Just 18 months after its February 2016 ... announce the appointment of three new senior people to ... Dominic Jones-Phillips and James Wright bring ... Tammy Wynne joins as ... writers. She has over ten years, experience in global ...
(Date:8/31/2017)... YORK , Aug. 31, 2017 PM360,s ... industry,s must-read guide to the latest innovations happening across ... first industry publication to focus on providing a comprehensive ... Ultimately, the issue covers the most innovative companies, startups, ... "Everyone in this ...
Breaking Medicine Technology: